» Articles » PMID: 22211188

Herbal Extracts and Phytochemicals: Plant Secondary Metabolites and the Enhancement of Human Brain Function

Overview
Journal Adv Nutr
Publisher Elsevier
Date 2012 Jan 3
PMID 22211188
Citations 146
Authors
Affiliations
Soon will be listed here.
Abstract

Humans consume a wide range of foods, drugs, and dietary supplements that are derived from plants and which modify the functioning of the central nervous sytem (CNS). The psychoactive properties of these substances are attributable to the presence of plant secondary metabolites, chemicals that are not required for the immediate survival of the plant but which are synthesized to increase the fitness of the plant to survive by allowing it to interact with its environment, including pathogens and herbivorous and symbiotic insects. In many cases, the effects of these phytochemicals on the human CNS might be linked either to their ecological roles in the life of the plant or to molecular and biochemical similarities in the biology of plants and higher animals. This review assesses the current evidence for the efficacy of a range of readily available plant-based extracts and chemicals that may improve brain function and which have attracted sufficient research in this regard to reach a conclusion as to their potential effectiveness as nootropics. Many of these candidate phytochemicals/extracts can be grouped by the chemical nature of their potentially active secondary metabolite constituents into alkaloids (caffeine, nicotine), terpenes (ginkgo, ginseng, valerian, Melissa officinalis, sage), and phenolic compounds (curcumin, resveratrol, epigallocatechin-3-gallate, Hypericum perforatum, soy isoflavones). They are discussed in terms of how an increased understanding of the relationship between their ecological roles and CNS effects might further the field of natural, phytochemical drug discovery.

Citing Articles

Enhanced Synthesis of Volatile Compounds by UV-B Irradiation in Leaves.

Gu H, Peng Z, Kuang X, Hou L, Peng X, Song M Metabolites. 2024; 14(12).

PMID: 39728481 PMC: 11678389. DOI: 10.3390/metabo14120700.


Chemical characterization, neuroprotective effect, and evaluation of the petroleum ether extract of three palm tree species against glutamate-induced excitotoxicity in rats.

Moharram F, Hamed F, El-Sayed E, Mohamed S, Ahmed A, Elgayed S Heliyon. 2024; 10(20):e39207.

PMID: 39640788 PMC: 11620252. DOI: 10.1016/j.heliyon.2024.e39207.


Hypoglycemic and antioxidant activities of L. with identification and characterization of phytocompounds.

Thakur M, Verma R, Kumar D, Manickam S, Ullah R, Ibrahim M Heliyon. 2024; 10(21):e39165.

PMID: 39524716 PMC: 11547964. DOI: 10.1016/j.heliyon.2024.e39165.


The potential of in alleviating mild cognitive impairment: a review.

Gao H, Lu H, Fang N, Su J, Li R, Wang W Front Pharmacol. 2024; 15:1484040.

PMID: 39494343 PMC: 11528016. DOI: 10.3389/fphar.2024.1484040.


Phytochemical Characterization and Assessment of Antioxidant and Anti-Alzheimer Effects of Algerian Seseli Tortuosum.

Slimani A, Akkal W, Acheraf Benmekhbi A, Mosbah A, Selim Cakmak Y, Lefahal M Chem Biodivers. 2024; 22(1):e202400482.

PMID: 39287103 PMC: 11741157. DOI: 10.1002/cbdv.202400482.


References
1.
Moulton P, Boyko L, Fitzpatrick J, Petros T . The effect of Ginkgo biloba on memory in healthy male volunteers. Physiol Behav. 2001; 73(4):659-65. DOI: 10.1016/s0031-9384(01)00510-8. View

2.
Cano Lozano V, Gauthier M . Effects of the muscarinic antagonists atropine and pirenzepine on olfactory conditioning in the honeybee. Pharmacol Biochem Behav. 1998; 59(4):903-7. DOI: 10.1016/s0091-3057(97)00524-8. View

3.
Orhan I, Kartal M, Kan Y, Sener B . Activity of essential oils and individual components against acetyl- and butyrylcholinesterase. Z Naturforsch C J Biosci. 2008; 63(7-8):547-53. DOI: 10.1515/znc-2008-7-813. View

4.
Bartus R, Dean 3rd R . Pharmaceutical treatment for cognitive deficits in Alzheimer's disease and other neurodegenerative conditions: exploring new territory using traditional tools and established maps. Psychopharmacology (Berl). 2008; 202(1-3):15-36. DOI: 10.1007/s00213-008-1365-7. View

5.
Haskell C, Kennedy D, Wesnes K, Scholey A . Cognitive and mood improvements of caffeine in habitual consumers and habitual non-consumers of caffeine. Psychopharmacology (Berl). 2005; 179(4):813-25. DOI: 10.1007/s00213-004-2104-3. View